EW vs GBIO · P/E 47, rev $3.39B vs rev $19.9M
Edwards Lifesciences Corp (EW) versus Generation Bio Co (GBIO) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Generation Bio Co (GBIO) is a biotechnology company listed on US.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported GBIO revenue for 2024-12-31 was $19.9M. Net income was -$131.7M. Revenue was up 236.9% from 2023-12-31 to 2024-12-31. GBIO currently screens at market cap $25.4M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. GBIO currently screens at market cap $25.4M.
Not investment advice. Open the EW and GBIO stock pages for the full models.
Not investment advice.